MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer. Wu Y, Huang J, Ivan C, Sun Y, et al. Gynecol Oncol 2021 Aug 11. pii: S0090-8258(21)00648.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu Y, Huang J, Ivan C, Sun Y, et al. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer. Gynecol Oncol 2021 Aug 11. pii: S0090-8258(21)00648.
PMID: 34391578